Know Cancer

or
forgot password

    • cancer clinical trials in burlington, VT

    • Thoracoscopy in Patients With Stage IIIA Non-Small Cell Lung Cancer
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Lung Cancer
    Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Brain and Central Nervous System Tumors
    Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Colorectal Cancer
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Anal Cancer
    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Brain and Central Nervous System Tumors
    Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Ovarian Cancer
    Topotecan in Treating Patients With Myelodysplastic Syndrome
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Leukemia, Myelodysplastic Syndromes
    Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Sarcoma
    Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Leukemia
    Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Lung Cancer
    Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Diarrhea, Radiation Enteritis
    Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Lymphoma
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Breast Cancer
    Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Leukemia
    Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Cardiac Toxicity, Sarcoma
    S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Lung Cancer
    S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Prostate Cancer
    Capecitabine in Treating Patients With Malignant Mesothelioma
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Malignant Mesothelioma
    Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Neuroblastoma
    Combination Chemotherapy in Treating Children or Adolescents With Newly Diagnosed Stage III or Stage IV Lymphoblastic Lymphoma
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Lymphoma
    Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Breast Cancer
    Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Anemia, Head and Neck Cancer
    Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Head and Neck Cancer
    Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Leukemia
    Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Leukemia
    S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Gastrointestinal Stromal Tumor
    Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Lung Cancer
    Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Leukemia, Lymphoma
    Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
    Fletcher Allen Health Care - Medical Center Campus
    Burlington, Vermont 05401
    Endometrial Cancer
    S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Leukemia
    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Lymphoma
    Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva
    Fletcher Allen Health Care - Medical Center Campus
    Burlington, Vermont 05401
    Vulvar Cancer
    Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Brain and Central Nervous System Tumors, Lymphoma, Neuroblastoma, Retinoblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    flt3L in Treating Patients With Acute Myeloid Leukemia
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Leukemia
    Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix
    Fletcher Allen Health Care - Medical Center Campus
    Burlington, Vermont 05401
    Cervical Cancer
    Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Leukemia
    Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Brain and Central Nervous System Tumors
    Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Head and Neck Cancer, Skin Reactions Secondary to Radiation Therapy
    Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Sarcoma
    Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Graft Versus Host Disease, Lymphoma
    Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Head and Neck Cancer, Oral Complications, Radiation Toxicity
    Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Breast Cancer
    Karenitecin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Lung Cancer
    Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Pancreatic Cancer
    Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer
    Fletcher Allen Health Care - Medical Center Campus
    Burlington, Vermont 05401
    Endometrial Cancer
    Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Ovarian Cancer
    Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Stage III Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage IVA Adult Soft Tissue Sarcoma, Stage IIB Adult Soft Tissue Sarcoma, Stage IIC Adult Soft Tissue Sarcoma
    Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    Lobradimil and Carboplatin in Treating Children With Brain Tumors
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Brain and Central Nervous System Tumors
    Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
    Fletcher Allen Health Care - Medical Center Campus
    Burlington, Vermont 05401
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Lymphoma
    Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia
    Vermont Cancer Center at University of Vermont
    Burlington, Vermont 05405-0075
    Leukemia
    Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Breast Cancer, Osteoporosis
    Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer
    Fletcher Allen Health Care - Medical Center Campus
    Burlington, Vermont 05401
    Prostate Cancer
    Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Fletcher Allen Health Care - Medical Center Campus
    Burlington, Vermont 05401
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Sarcoma
    Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer
    Vermont Cancer Center

    Trial Locations
    Vermont Cancer Center
    Fletcher Allen Health Care - University Health Center Campus
    Colorectal Cancer